Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation AVIC 2020

Tratamiento Antitrombótico Después De La Tavi

Presenter: José Luis Ferreiro

January 31, 2020

Presentation

Impact of Preexisting and New-Onset A-fib on TAVR Outcomes

October 18, 2019

Presentation TCT Abstracts Posters 2019

In-hospital Outcomes of Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: Nationwide Database Analysis

Presenter: Fangcheng Wu

September 29, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation ARCH 2019

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Presenter: David G. Rizik

April 11, 2019

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

Presentation SWVS 2017

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Presenter: Ankur Kalra

May 06, 2017

Presentation CRT 2017

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Presenter: Chadi Alraies

February 22, 2017

Presentation

Apixaban in Patients With Atrial Fibrillation After TAVR

Presenter: J. Seeger

January 03, 2017

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Presenter: Philippe Généreux

June 16, 2016

Presentation

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

Presenter: Angelo Biviano

January 07, 2016

Presentation

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Presenter: R. Chopard

August 27, 2015

Presentation

Atrial Fibrillation, Stroke, and Mortality Rates Following TAVI

Presenter: Lior Yankelson

October 13, 2014

Presentation TCT 2014

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Presenter: T. Tanawuttiwat

January 29, 2014

Presentation TVT 2013

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

Presenter: Josep Rodes-Cabau

June 12, 2013

Presentation

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

Presenter: S. Stortecky

February 10, 2013

Advertisement

Tratamiento Antitrombótico Después De La Tavi

Impact of Preexisting and New-Onset A-fib on TAVR Outcomes

In-hospital Outcomes of Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: Nationwide Database Analysis

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Results From The BRAVO 3 Randomized Trial

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Apixaban in Patients With Atrial Fibrillation After TAVR

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Atrial Fibrillation, Stroke, and Mortality Rates Following TAVI

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content